Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) Operating Expenses (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of Operating Expenses data on record, last reported at $159.9 million in Q4 2025.

  • For Q4 2025, Operating Expenses fell 13.91% year-over-year to $159.9 million; the TTM value through Dec 2025 reached $567.7 million, down 8.14%, while the annual FY2025 figure was $567.7 million, 8.14% down from the prior year.
  • Operating Expenses reached $159.9 million in Q4 2025 per TCNNF's latest filing, up from $127.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $432.9 million in Q2 2023 and bottomed at $62.7 million in Q1 2021.
  • Average Operating Expenses over 5 years is $150.1 million, with a median of $138.5 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: soared 200.3% in 2023, then tumbled 69.53% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $144.0 million in 2021, then rose by 5.51% to $151.9 million in 2022, then decreased by 17.93% to $124.7 million in 2023, then soared by 48.96% to $185.7 million in 2024, then decreased by 13.91% to $159.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $159.9 million in Q4 2025, $127.6 million in Q3 2025, and $130.3 million in Q2 2025.